Cancer care
Optimising oncology outcomes: New data on the benefits of high-protein Omega-3 enriched ONS
Dr. Petra Beran Holečková
Institute of Radiation Oncology, Faculty Hospital Bulovka, Prague, Czechia
Dr. Petra Beran Holečková shares new data on the benefits of high-protein Omega-3 enriched oral nutritional supplements (ONS) in cancer care. Her presentation presents insights on a multi-center study involving adult outpatients receiving anti-cancer treatment who were either malnourished or at risk of malnutrition. Participants received 2 servings of Forticare Advanced, a high-protein, Omega-3 enriched ONS, for three months. Dr. Beran Holečková highlights key outcomes, including body weight and compliance, while also evaluating secondary measures such as C-reactive protein, hand grip strength, physical performance, and patient-reported outcomes throughout the intervention.